Research Partnerships & Affiliations

DHR HEALTH

DHR Health (DHR) is a 500+ bed physician-owned tertiary health system that offers some of the most comprehensive medical care on the U.S. Southern Border. Over 670 physicians and more than 1,800 nursing professionals dedicate themselves to offering a full continuum of care in over 70 different sub-specialties, from general acute care services and graduate medical education to individually tailored wellness and preventative health programs.

DHR was founded in 1997 to help the now 1.2 million residents in our region resolve limited health care access challenges in a community that lacked public and county hospitals. Today, DHR is working to forge a new integrated health care delivery model that incorporates patient navigation electronic medical records, population-based care, and superior quality and efficiency to meet every patient’s health needs.

To learn more, please visit DHRHealth website www.dhrhrealth.com.

THE RENAISSANCE MEDICAL FOUNDATION

In 2011, the Renaissance Medical Foundation (RMF) was created at DHR Health to help fill in the gaps of specialty medical services available in the Rio Grande Valley.

Since inception, the RMF has established 37 primary and specialty service lines, including gastroenterology, neuroscience, bariatrics, urology and endocrinology, among many others.

The unique specialty services that the RMF offers range from Starr County, throughout Hidalgo County, and into Cameron County (red dots indicate future location of specialty clinics).

Renaissance Medical Foundation Locations

REACHnet

https://reachnet.org

DHR Health Institute for Research & Development has partnered with REACHNet, a partnership of health systems, academic centers, and public health organizations that constitutes an innovative data network for conducting efficient, multi-site research (https://reachnet.org/researchers).

Through this partnership we will be facilitating patient-centered clinical and health outcomes research.

Organized under the tutelage of Louisiana Public health Institute and funded by PCORI, other members of this consortium include:

PARTNERS IN INNOVATION, EDUCATION AND RESEARCH

Pier Consortium

The Partners in Innovation, Education and Research Consortium (PIER Consortium™) is a collaborative network of health systems offering an entrepreneurial approach to clinical research.

The focus is to streamline the clinical research process, accelerate clinical trials, and facilitate the sharing of innovative ideas across the consortium. PIER’s unique infrastructure leverages the services, expertise and scientific leadership from each member to improve the lives of our patients and communities.

DHR Health Institute for Research & Development is an Associate Member of PIER and is engaged in bringing cutting edge clinical trials to the Rio Grande Valley.

The other members of PIER are:

VANDERBILT UNIVERSITY MEDICAL CENTER

C3FIT – AN INTEGRATED POST-STROKE PRACTICE UNIT MODEL

Stroke is a serious and debilitating disorder with very high morbidity and mortality.
Stroke is the fifth leading cause of death for Americans; kills about 140,000 Americans each year.

Someone in the United States has a stroke every 40 seconds and every 4 minutes someone dies of stroke.

The recurrence of stroke in patients who previously had a stroke is about 1:4 and it costs the United States estimated $34 billion each year.

Though stroke rates have declined for decades among all races/ethnicities – Hispanics, however, have seen an increase in death rates due to stroke since 2013.

To learn more about Stroke, please visit this website: https://www.cdc.gov/stroke/facts.htm

To transform post-stroke care of patients in the Rio Grande Valley, DHR Health Institute for Research & Development has partnered with 17 other Tier I institutions nation-wide, to participate in the development and re-engineering of post-stroke care in the community. 

The consortium is led by Vanderbilt University and has the following institutions as participating sites:

To learn more about this Federally funded trial, please visit this website: https://c3fit.dialogedu.com/c3fit-partner-site/ or contact the relevant staff in DHR Health Institute for Research & Development.

UTRGV

UTRGV

UTRGV is a public research university in the University of Texas System. UTRGV has multiple campuses in the Rio Grande Valley region of Texas; founded in 2013, it entered into full operation in 2015 after the consolidation of the University of Texas at Brownsville/Texas Southmost College, the University of Texas-Pan American and the UT Regional Academic Health Center – Harlingen.

DHR Health Institute for Research & Development has strong research partnership with UTRGV and its School of Medicine. The two institutions are working very closely in many areas of basic, translational and clinical research.

DHR Health System – our major research affiliate, is a clinical training site for medical students, residents and fellows of UTRGV School of Medicine. As such, many faculty, students, residents and fellows are involved in clinical research under the auspices of the DHR Health Institute for Research & Development.

WIRB-COPERNICUS GROUP (WCG)

WCG is the joining of two revolutionary companies (Western Institutional Review Board and Copernicus Group) with a common goal to provide the researchers who perform clinical trials with the highest quality of services to accelerate the scientific advancement of human health, while ensuring that the risks of progress never outweigh the value of human life. WCG strives to speed study start-up, reduce cost, improve data quality, and ensure compliance of research projects.

Our affiliation with WCG will ensure that all regulatory and compliance standards are met when conducting clinical trials. DHR Health Institute for Research & Development will benefit from the world’s largest Institutional Review Board-Institutional Biosafety Committee network with oversight of more than 200,000 protocols covering virtually every therapeutic indication and help provide our organization with modernizing and digitizing the IRB processes, and making our IRB office more efficient. WCG will also help us engage and access some of the world’s best clinical trials and simplify the management of our entire clinical research portfolio by linking study status, patient enrollment, calendars, budgets, electronic data capture and more.

To learn more about WCG, please visit this website: http://wcgclinical.com/ 

COVANCE RESEARCH ORGANIZATION

Covance is a global contract research organization. Contract research organizations (CROs) provide clinical trial management and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations, and universities.

In the changing economy, pharmaceutical companies are increasingly looking to outsource critical functions, including manufacturing and research. More and more of the major corporations are using CROs to lead clinical trials and develop new medications.

Covance manages almost all aspects of a clinical trial, from site selection and patient enrollment through final regulatory approval from the Food and Drug Administration and European Medicines Agency.

Covance has partnered with the leading pharmaceutical companies that have developed some of the world’s cutting edge new medications. Partnering with Covance will allow DHR Health Institute for Research & Development to give our patients access to these innovative clinical trial and front-line medications.

PINNACLE CLINICAL RESEARCH

Lead by Dr. Stephen Harrison, a world-renowned leader in liver diseases, Pinnacle Clinical Research is dedicated to conducting late phase clinical trials in the areas of Hepatology and Gastroenterology, with a special focus on fatty liver disease. With the high incidence of fatty liver in the Rio Grande Valley, this exclusive partnership between DHR Health Institute for Research & Development and Pinnacle Clinical Research will be extremely valuable for our community. Clinical trials are conducted in the following areas:

  • Non-alcoholic fatty liver disease
  • Hepatitis B and C
  • Primary biliary cholangitis (PBC)
  • Primary sclerosis cholangitis (PSC)
  • Portal hypertension
  • Ulcerative colitis
  • Crohn’s disease
  • Gastroparesis
TRINETX

TriNEtX is a global health research network that optimizes clinical research; provides real-time access to longitudinal clinical data with state-of-the-art analytics.

www.trinetx.com